Noninvasive assessment of coronary microvascular function in women at risk for ischaemic heart disease

International Journal of Clinical Practice

Volumn 62, Issue 2, 2008, Pages 300-307

  Campisi, R ^a,b  

^a Fundación Centro Diagnóstico Nuclear   (Argentina)

^b NONE   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE RECEPTOR STIMULATING AGENT; DIPYRIDAMOLE; ESTROGEN; GESTAGEN; PROGESTERONE; RADIOISOTOPE; TIBOLONE;

ANGIOCARDIOGRAPHY; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; DRUG EFFECT; ELECTROCARDIOGRAM; HEART FUNCTION; HEART MUSCLE BLOOD FLOW; HUMAN; HYPEREMIA; ISCHEMIC HEART DISEASE; MEDICAL ASSESSMENT; MICROVASCULATURE; NON INVASIVE PROCEDURE; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; POSTMENOPAUSE; PRIORITY JOURNAL; RADIODIAGNOSIS; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THORAX PAIN; WOMEN'S HEALTH;

CORONARY CIRCULATION; CORONARY VESSELS; DIABETIC ANGIOPATHIES; ENDOTHELIUM, VASCULAR; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MICROCIRCULATION; MUSCLE, SMOOTH, VASCULAR; MYOCARDIAL ISCHEMIA; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS;

EID: 38149059110     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2007.01391.x     Document Type: Review

References (61)

1. Stampfer M, Colditz G, Willett W et al. Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the nurses' health study. N Engl J Med 1991 265 : 1861 7.
2. Johnson PA, Manson JE. How to make sure the beat goes on. Circulation 2005 111 : e28 33.
3. Mosca L, Grundy SM, Judelson D et al. Guide to preventive cardiology for women: AHA/ACC Scientific Statement: consensus panel statement. Circulation 1999 99 : 2480 4.
4. Bugiardini R, Bairey Merz CN. Angina with ''normal" coronary arteries. JAMA 2005 293 : 477 84.
5. Reis SE, Holubkov R, Conrad Smith AJ et al. Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study. Am Heart J 2001 141 : 735 41.
6. von Mering GO, Arant CB, Wessel TR et al. Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women. Results form the National Heart, Lung and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation [WISE]. Circulation 2004 109 : 722 5.
7. Pepine CJ, Kerensky RA, Lambert CR et al. Some thoughts on the vasculopathy of women with ischemic heart disease. J Am Coll Cardiol 2006 47 : 30S 5S.
8. Furchgott RF, Zawadski JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980 288 : 373 76.
9. Nathan L, Chaudhuri G. Estrogens and atherosclerosis. Annu Rev Pharmacol Toxicol 1997 37 : 477 515.
10. Yang Y, Loscalzo J. Regulation of tissue factor expression in human microvascular endothelial cells by nitric oxide. Circulation 2000 101 : 2144 8.
11. Quyyumi AA. Women and Ischemic Heart Disease. Pathophysiology Implications from the Women's Ischemia Syndrome Evaluation [WISE] Study and future research steps. J Am Coll Cardiol 2006 47 : 66S 71S.
12. Marroquin OC, Holubkov R, Edmundowicz D et al. Heterogeneity of microvascular dysfunction in women with chest pain not attributable to coronary artery disease: implications for clinical practice. Am Heart J 2003 145 : 628 35.
13. Marroquin OC, Kip KE, Mulukutla SR et al. Inflammation, endothelial cell activation, and coronary microvascular dysfunction in women with chest pain and no obstructive coronary artery disease. Am Heart J 2005 150 : 109 15.
14. Bugiardini R, Manfrini O, Pizzi C et al. Endothelial function predicts future development of coronary artery disease: a study on women with chest pain and normal angiograms. Circulation 2004 109 : 2518 23.
15. Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000 101 : 1899 906.
16. Bairey Merz CN, Shaw LJ, Reis SE et al. Insights from the NHLBI-sponsored women's ischemia syndrome evaluation (WISE) study. J Am Coll Cardiol 2006 47 : 21S 9S.
17. Nabel EG, Ganz P, Gordon JB, Alexander RW, Selwyn AP. Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test. Circulation 1988 77 : 43 52.
18. Zeiher AM, Drexler H, Wollschlaeger H, Saurbier B, Just H. Coronary vasomotion in response to sympathetic stimulation in humans: importance of the functional integrity of the endothelium [see comments]. J Am Coll Cardiol 1989 14 : 1181 90.
19. Nitenberg A, Valensi P, Sachs R, Dali M, Aptecar E, Attali JR. Impairment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes 1993 42 : 1017 25.
20. Ronderos RE, Boskis M, Chung N et al. Correlation between myocardial perfusion abnormalities detected with intermittent imaging using intravenous perfluorocarbon microbubbles and radioisotope imaging during high-dose dipyridamole stress echo. Clin Cardiol 2002 25 : 103 11.
21. Ibrahim T, Nekolla SG, Schreiber K et al. Assessment of coronary flow reserve: comparison between contrast-enhanced magnetic resonance imaging and positron emission tomography. J Am Coll Cardiol 2002 39 : 864 70.
22. Shaw LJ, Bairet Merz CN, Pepine CJ et al. Insights From the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J Am Coll Cardiol 2006 47 : 4S 20S.
23. Kuhle WG, Porenta G, Huang SC et al. Quantification of regional myocardial blood flow using 13N-ammonia and reoriented dynamic positron emission tomographic imaging. Circulation 1992 86 : 1004 17.
24. Muzik O, Beanlands RS, Hutchins GD, Mangner TJ, Nguyen N, Schwaiger M. Validation of nitrogen-13-ammonia tracer kinetic model for quantification of myocardial blood flow using PET. J Nucl Med 1993 34 : 83 91.
25. Campisi R, Di Carli MF. Assessment of coronary flow reserve and microcirculation: a clinical perspective. J Nucl Cardiol 2004 1 : 3 11.
26. Udelson JE, Heller GV, Wackers FJ et al. Randomized, controlled dose-ranging study of the selective adenosine A2A receptor agonist binodenoson for pharmacological stress as an adjunct to myocardial perfusion imaging. Circulation 2004 109 : 457 64.
27. Schindler TH, Schelbert HR. Measurements of myocardial blood flow and monitoring therapy. In : Zaret BL, Beller GA, eds. Clinical Nuclear Cardiology: State of the Art and Future Directions, 3rd edn. Philadelphia, PA : Elsevier Mosby 2005 : 399 412.
28. Maddahi J. Myocardial perfusion imaging for the detection and evaluation of coronary artery disease. In : Skorton DJ, Schelbert HR, Wolf GL, Brundage BH, eds. Marcus Cardiac Imaging, 2nd edn. Philadelphia, PA : Saunders Company, 1996 : 971 995.
29. Buus NH, Bottcher M, Hermansen F et al. Influence of nitric oxide synthase and adrenergic inhibition on adenosine-induced myocardial hyperemia. Circulation 2001 104 : 2305 10.
30. Zeiher AM, Drexler H, Wollschläger H et al. Endothelial dysfunction of the coronary microvasculature is associated with coronary blood flow regulation in patients with early atherosclerosis. Circulation 1991 84 : 1984 92.
31. Campisi R, Czernin J, Schoeder H et al. l-Arginine normalizes coronary vasomotion in long-term smokers. Circulation 1999 99 : 491 7.
32. Kichuk MR, Seyedi N, Zhang X et al. Regulation of nitric oxide production in human coronary microvessels and the contribution of local kinin formation. Circulation 1996 94 : 44 51.
33. Peterson LR, Eyster D, Davila-Roman VG et al. Short-term oral estrogen replacement therapy does not augment endothelium-independent myocardial perfusion in postmenopausal women. Am Heart J 2001 142 : 641 7.
34. Campisi R, Nathan L, Pampaloni MH et al. Noninvasive assessment of coronary microcirculatory function in postmenopausal women and effects of short-term and long-term estrogen administration. Circulation 2002 105 : 425 30.
35. Duvernoy C, Martin J, Briesmiester K et al. Myocardial blood flow and flow reserve in response to hormone therapy in postmenopausal women with risk factors for coronary disease. J Clin Endocrinol Metab 2004 89 : 2783 8.
36. Cicinelli E, Ignarro LJ, Matteo MG et al. Effects of estrogen replacement therapy on plasma levels of nitric oxide in postmenopausal women. Am J Obstet Gynecol 1999 180 : 334 9.
37. Di Carli MF, Hachamovitch R. Should we screen for occult coronary artery disease among asymptomatic patients with diabetes? J Am Coll Cardiol 2005 45 : 50 3.
38. Di Carli MF, Janisse J, Grunberger G, Ager J. Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J Am Coll Cardiol 2003 41 : 1387 93.
39. Berman DS, Kang X, Hayes SW et al. Adenosine myocardial perfusion single-photon emission computed tomography in women compared with men. Impact of diabetes mellitus on incremental prognostic value and effect on patient management. J Am Coll Cardiol 2003 41 : 1125 33.
40. Di Carli MF, Afonso L, Campisi R et al. Coronary vascular dysfunction in premenopausal women with diabetes mellitus. Am Heart J 2002 144 : 711 8.
41. Hachamovitch R, Berman DS, Kiat H et al. Effective risk stratification using exercise myocardial perfusion SPECT in women: gender-related differences in prognostic nuclear testing. J Am Coll Cardiol 1996 28 : 34 44.
42. Mieres JH, Shaw LJ, Arai A et al. Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease. Circulation 2005 111 : 682 96.
43. Heupler S, Mehta R, Lobo A et al. Prognostic implications of exercise echocardiography in women with known or suspected coronary artery disease. J Am Coll Cardiol 1997 30 : 414 20.
44. Arruda-Olson AM, Juracan EM, Mahoney DW et al. Prognostic value of exercise echocardiography in 5798 patients: Is there a gender difference? J Am Coll Cardiol 2002 39 : 625 631.
45. Shaw LJ, Vasey C, Sawada S et al. Impact of gender on risk stratification by exercise and dobutamine stress echocardiography: long-term mortality in 4232 women and 6898 men. Eur Heart J 2005 26 : 447 56.
46. Lerman A, Sopko G. Women and cardiovascular heart disease: clinical implications from the Women's Ischemia Syndrome Evaluation (WISE) study. J Am Coll Cardiol 2006 47 : 59S 62S.
47. Al Suwaidi J, Reddan DN, Williams K et al. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation 2002 106 : 974 80.
48. Halcox JP, Schenke WH, Zalos G et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 2002 106 : 653 8.
49. Schindler TH, Hornig B, Buser PT et al. Prognostic value of abnormal vasoreactivity of epicardial coronary arteries to sympathetic stimulation in patients with normal coronary angiograms. Arterioscler Thromb Vasc Biol 2003 23 : 495 501.
50. Clarkson P, Celermajer DS, Donald AE et al. Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels. J Am Coll Cardiol 1996 28 : 573 9.
51. Wessel TR, Arant CB, McGorray SSP et al. Coronary vascular dysfunction is only partially predicted by traditional cardiovascular risk factors in women undergoing evaluation for suspected ischemia: results from the NHLBI Women's Ischemia Syndrome Evaluation [WISE] study. J Am Coll Cardiol 2004 43 (Suppl. A) 484A [Abstract].
52. Pepine CJ. Ischemic heart disease in women: the role of coronary microvascular dysfunction. Trans Am Clin Climatol Assoc 1999 110 : 107 16.
53. Reis SE, Holubkov R, Lee JS et al. Coronary flow velocity response to adenosine characterizes coronary microvascular function in women with chest pain and no obstructive coronary disease-results from the pilot phase of the Women's Ischemia Syndrome Evaluation [WISE] study. J Am Coll Cardiol 1999 33 : 1469 75.
54. Taddei S, Virdis A, Ghiadoni L et al. Menopause is associated with endothelial dysfunction in women. Hypertension 1996 28 : 576 82.
55. Reis S, Gloth S, Blumenthal R et al. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation 1994 89 : 52 60.
56. Hulley S, Grady D, Bush T et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998 280 : 605 13.
57. Rossouw JE, Anderson GL, Prentice RL et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized control trial. JAMA 2002 288 : 321 33.
58. Pervin S, Singh R, Rosenfeld ME et al. Estradiol suppresses MCP-1 expression in vivo: implications for atherosclerosis. Arterioscler Thromb Vasc Biol 1998 18 : 1575 82.
59. Nathan L, Pervin S, Singh R et al. Estradiol inhibits leukocyte adhesion and transendothelial migration in rabbits in vivo: possible mechanisms for gender differences in atherosclerosis. Circ Res 1999 85 : 377 85.
60. Grodstein F, Manson JE, Stampfer MJ. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation. J Womens Health 2006 15 : 35 44.
61. Campisi R, Camilletti J, Mele A et al. Tibolone improves myocardial perfusion in postmenopausal women with ischemic heart disease. J Am Coll Cardiol 2006 47 : 559 64.